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Abstract The Australian Clinical Dosimetry Service
(ACDS) has demonstrated the capacity to perform a basic
dosimetry audit on all radiotherapy clinics across Australia.
During the ACDS’s three and a half year trial the majority
of the audits were performed using optically stimulated
luminescence dosimeters (OSLD) mailed to facilities for
exposure to a reference dose, and then returned to the
ACDS for analysis. This technical note investigates the
stability of the readout process under the large workload of
the national dosimetry audit. The OSLD readout uncer-
tainty contributes to the uncertainty of several terms of the
dose calculation equation and is a major source of uncer-
tainty in the audit. The standard deviation of four OSLD
readouts was initially established at 0.6 %. Measurements
over 13 audit batches—each batch containing 200-400
OSLDs—showed variability (0.5-0.9 %) in the readout
standard deviation. These shifts have not yet necessitated a
change to the audit scoring levels. However, a standard
deviation in OSLD readouts greater than 0.9 % will change
the audit scoring levels. We identified mechanical wear on
the OSLD readout adapter as a cause of variability in
readout uncertainty, however, we cannot rule out other
causes. Additionally we observed large fluctuations in the
distribution of element correction factors (ECF) for OSLD
batches. We conclude that the variability in the width of the
ECF distribution from one batch to another is not caused by
variability in readout uncertainty, but rather by variations
in the OSLD stock.
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Introduction
Performing an independent and standardised audit is an
internationally recognised way to minimise the risk of a
dosimetric error in radiotherapy practice [1]. The Austra-
lian Clinical Dosimetry Service (ACDS) conducts a level
one postal audit using optically stimulated luminescence
dosimeters (OSLD, nanoDots (Landauer, Inc., Glenwood,
IL), encased in Perspex blocks to determine the absorbed
dose to water per monitor unit for MV photon and electron
beams under reference conditions. The audit is based on
the well-established methodology of imaging and radiation
oncology core (IROC) Houston QA Center (formerly
Radiological Physics Center (RPC)) [2] and is explained in
detail by Lye et al. [3]. The characterisation of OSLDs for
use in clinical dosimetric measurements has been reported
by Jursinic [4], by the International Atomic Energy Agency
[5], and undertaken specifically in the context of the ACDS
audit by Dunn et al. [6].
A key component of any audit is the pass/fail tolerance.
The ACDS level one audit tolerance was defined using a
rigorous uncertainty calculation [3]. It is important for the
ACDS to monitor the individual uncertainty components
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and ensure that they do not drift over time. A significant
uncertainty component that could be susceptible to drift is
the OSLD MicroStar (Landauer, Inc., Glenwood, IL)
reader stability. In this technical note we monitor multiple
OSLD read outs, specifically the standard deviation of four
reads, over a period of 3 years since mid-2011. We
examine a large data set from field trial audit batches and
fully commissioned audit batches. The field trial phase was
used to establish the audit methodology and uncertainty
which was then followed by the fully commissioned phase
where audit scores were generated from the audit results
and known uncertainty. The inclusion of electron beams in
the most recent batches has increased the number of OS-
LDs required to perform an audit. We also anticipate a
growth in the number of Australian radiotherapy linacs,
and there is potential to use OSLDs to perform higher lever
audits or quality assurance beyond basic dosimetry [7, 8]
similar to the use of radiochromic film and thermolumi-
nescent dosimetry capsules in higher level audits [9]. It is
timely to establish protocols to examine an OSLD reader’s
long term stability, under an ever increasing workload.
Method
The ACDS performed quarterly OSLD mail outs to an
ensemble of facilities. For each quarterly mail out a batch
of OSLDs was prepared. The readout analysis was per-
formed independently for each batch. Field trails and early
audit batches contained 200-400 OSLDs. Since the
inclusion of electron audits in September 2013 all batches
have contained 400-450 OSLDs.
An initial read on each OSLD determined the signal
from the un-irradiated OSLD, read(un-irr). The batch was
then exposed to 1 Gy using an Eldorado Co-60 unit. To
ensure uniform dose to all OSLDs, groups of eight OSLDs
were located in a 2.5 cm radius ring around the centre of a
10 9 10 cm2 field at 5 cm depth in solid water (20 cm
backscatter) with a source to surface distance (SSD) of
100 cm. The raw OSLD signal, proportional to the emitted
light of the OSLD, readj, was corrected for reader deple-
tion of 0.03 % per read [6]. An average of the signal from
four reads was taken and the initial un-irradiated read value
was subtracted to return the value counts(bg) (Eq. 1). The









The normalised standard deviation of the four reads,
rread, and element correction factor, ECF, (Eq. 2) for each
OSLD was determined. The letter i in Eq. 2 represents the







In the field trial (batches 4-7) the set of four reads was
performed once. To decrease the audit uncertainty in sub-
sequent batches (batches 8-16), the read outs were per-
formed in two separate sets to make a total of eight reads.
This paper intends to find if the mean rread value in a batch
has remained constant since the conclusion of the field
trials and to also gauge how shifts in mean rread will affect
the audit’s uncertainty budget.
The audit results are determined by the deviation of the
facility stated dose from the ACDS measured dose, defined
in Eq. 3 where Dfac is the dose quoted from the facility
under audit and Dref is the dose determined by the ACDS
found using Eqs. 4 and 5:
Audit Result¼Dfac  Dref
Dref
ð3Þ
Dref ¼ Daudit  BF ð4Þ
Daudit ¼ Counts kr  Counts bgð Þ  kr bgð Þ  kf bgð Þ
  kf
 
 ECF  S kE  kL
ð5Þ
The block factor (BF), converts Daudit, the Perspex block
dose, to Dref, the dose in water under reference conditions.
Counts is the output of the OSLD reader after facility
irradiation, averaged from eight readings and corrected for
reader depletion. The subscript, bg, refers to a reading
made on the OSLD after it is irradiated to 1 Gy in 60Co to
determine the ECF prior to delivery of the audit kit to the
facility. kr, kf, kE, and kL are the reader, fading, energy, and
non-linearity corrections, respectively (more detail given in
Lye et al. [3]). S is the batch sensitivity, in cGy/counts, to
1 Gy of 6 MV photons.
The audit outcome is based on a relative combined
standard uncertainty (raudit) of 1.3 %. The outcome is
categorised as either pass (optimal level) when the score is
B2raudit, pass (action level) when the score is[2raudit, or
fail when the score is[3raudit. The uncertainty budget has
contributions from the uncertainty in delivering dose at the
facility and the uncertainty in measuring the OSLD dose at
the ACDS. This budget is shown in detail in the ACDS’s
previous publication [3], and in Tables 1 and 2 below.
Several of the uncertainties in the measurement of the
OSLD are type A [10] having been evaluated by statistical
analysis through the commissioning of the audit
methodology.
The variables Counts, Counts(bg), ECF, and S are all
determined through multiple reads of OSLDs and are
susceptible to drift in the reader stability. These uncertainty
components are italicised in Table 1. The uncertainties
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assigned to Counts, Counts(bg), and ECF, in the Daudit
uncertainty budget are all derived from ECF readout data
with the assumption that the uncertainty in delivering the
same dose to each OSLD in the batch is negligible.
Readout uncertainty, Uread, is defined as the normalised
standard deviation of the readouts, rread, divided by the
square root of the number of reads.
Continued statistical analysis over many audits to
evaluate the uncertainty in these variables provides a
dynamic assessment of the OSLD reader’s functional sta-
bility. Wear on the reader’s mechanical parts, contamina-
tion in optical components, and faults with electronic
components may all give rise to a greater uncertainty in
determining the audit dose and therefore the audit out-
comes must be adjusted accordingly. Further, any increase
in the dose measurement uncertainty will lessen the audit’s
ability to find dosimetric errors in Australian radiotherapy.
It is crucial for the ACDS to be fully aware of, and take
remedial action to counter, any rise in measurement
uncertainty.
The batch sensitivity, S, is determined through multiple
readouts of a sub-batch of OSLDs that have been exposed
to a nominal dose of 1 Gy (6 MV photons, TPR20,10 =
0.673) under reference conditions (10 cm depth, 90 cm
SSD) in solid water using the Australian Radiation Pro-
tection and Nuclear Safety Agency’s Elekta Synergy
(Elekta AB, Stockholm, Sweden) linac. In this technical
note the uncertainty in S is not discussed in detail, however,
it is worthy to note that an increase in Uread, will also
increase the uncertainty in S.
Results
To visually summarise the readout results, ECF is plotted
against rread for each OSLD in the batch in Figs. 1, 2, 3
and 4. Histograms have been inserted on the vertical and
horizontal axes to show the distributions of ECFs and rread
respectively. The inset number on the horizontal histogram
is the mean of all the rread values for the batch. It was
found that on occasion a single read could return an
anomalous value and rread of four reads would appear as an
outlier, away from the main peak. The anomalous readings
are generally always low and we attribute their presence to
operator error, that is, an unintentional turn of the readout
dial back to home position prematurely, or a mechanical
failure of the positioning dial to correctly position the
OSLD in the light field.
Figure 1 displays the results for the field trial batches
(4-7) showing the distributions of rread. The mean rread
value ranges from 0.57 to 0.70 %. The mean across all
batches is 0.63 %, and the standard deviation of the rread
values is 0.3 %. This number is in agreement with the
reading uncertainty quoted by Mrcˇela et al. [11] of
(0.6 ± 0.3) %. When eight reads are conducted Uread for
the level one audit has been calculated, based on the field
trail result, to be 0.22 %. The uncertainty in the mean of
the rread value is ±0.02 %—very low because of the large
number of OSLDs in the batches. We regard a shift in
mean rread that is greater than ±3 9 0.02 % to be due to
reader instability.
The first four audit batches (8-11) in Fig. 2 showed a
similar stability to the field trial results with the mean rread
ranging from 0.55 to 0.74 %. In batch 12, shown in Fig. 3,
the mean rread was found to be 0.94 % in the second OSLD
read out session. This increase is enough to change the
Table 1 Relative standard uncertainties for the ACDS measured
dose
Quantity ACDS relative standard
uncertaintya
100 uiA 100 uiB
Counts 0.22b –
Background counts 0.22b –
Reader correction – 0.14
Background reader correction – 0.14
Fading correction – 0.07
Background fading correction – 0.07
Element correction factor 0.22b –
Sensitivity 0.50b –
Energy correction 0.43 –
Non-linearity correction – 0.04
Block factor 0.44 0.30
Reference distance – 0.20
Quadratic summation: 0.88 0.42
Combined relative standard uncertainty: 1.0
a Sub heading definitions: 100 uiA represents type A uncertainties
expressed as a percentage, 100 uiB represents type B uncertainties
expressed as a percentage
b Uncertainties which are susceptible to drift in the reader stability
Table 2 Combination of uncertainties for both the ACDS measured
dose and the facility measured dose. A combined relative standard





100 uiA 100 uiB
ACDS measured dose 0.88 0.42
Facility measured dose 0.02 0.92
Quadratic summation 0.88 1.01
Combined relative standard uncertainty (raudit) 1.3
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least significant figure in the relative combined standard
uncertainty for the level one audit, from 1.3 to 1.4 %. To
counter this increase the second ACDS OSLD reader was
examined with a new nanoDot adapter. We found that the
mean rread value was reduced to 0.51-0.54 %, a level
lower to that found in the audit field trials and early audits.
The continued use of reader 2 in batches 13-15 showed a
gradual increase in mean rread until batch 16, when a new
OSLD nanoDot adapter was used.
In Fig. 6 the width of the ECF distribution, ECFwidth is
plotted against mean rread for all batch readouts. This
width is defined as the standard deviation of all the ECF
values in a batch. The data is plotted in this way to
determine whether, or not, the distribution of ECF values
remains constant over different batches. The ECFwidth
varies from 2 to 5 % and it is not correlated with mean
rread.
Discussion
The reader instability is summarised in the plot shown in
Fig. 5. A batch readout session returns individual rread
values for each OSLD in the batch. The mean rread values
have been plotted for each read out session of each batch.
The mean rread values from the field trial batches was used
to define Uread which in turn affects the relative combined
Fig. 1 The ECF plotted against rread for batches 4–7 (field trial batches). The mean rread varies from 0.57 to 0.70 %. The field trial batches have
established the typical range of rread that a group of four read outs produces
Fig. 2 ECF plotted against rread for batches 8–11 (audit batches).
The mean rread varies from 0.55 to 0.74 %. A similar result to the
field trial batches indicates the reader is operating stably. Unlike the
field trials, the ECF read was conducted on two separate sessions,
shown here as two groups of data coloured blue and black
Fig. 3 ECF plotted against rread for batch 12. For reader 1 the mean
rread varies from 0.79 to 0.94 %. This result indicates the reader
stability has deteriorated. The read outs were then performed on
reader number 2 (coloured red and black) and mean rread
(0.51–0.54 %) was found to be at previously accepted values
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standard uncertainty, raudit, as shown in Tables 1 and 2.
The uncertainty in the mean rread value in a single readout
session has been calculated to be ±0.02 %, signified by
size of the markers in Fig. 5. Because shifts in the mean
rread value are greater than this uncertainty we can attribute
these shifts to real variability in the process and not sta-
tistical fluctuations. Recalculated audit scoring tolerances,
raudit, due to an increase in rread, are marked as dashed
lines in Fig. 5. A mean standard deviation in OSLD read-
outs greater than 0.9 % will change the audit scoring lev-
els. The result from batch 12, reader 1, are close to limit
(when averaging two readout sessions), and without the
remedial action of changing the reader and nanoDot
adapter this limit may have been exceeded due to the
failing mechanical action of the worn adapter.
If rread was the only contributor to the distribution of
ECF values, that is, if all ECFs were equal to unity, and
measured ECFs were only due to measurement uncertainty,
then ECFwidth would on average be approximately equal to
rread divided by the square root of the number of reads.
This relationship is plotted as a line in Fig. 6 and the fact
that the experimental data lies away from this relationship
indicates that the ECF variation in a group of dosimeters is
greater than the measurement uncertainty. This data
strongly re-asserts the advantage of using individual ECFs
[6]. Additionally, there is variability in the OSLD stock
from one batch to another meaning that one cannot rely on
the batches always having a similar range and distribution
of ECFs and the width of the ECF peak is not a useful
metric to describe the quality of the readout session.
Conclusion
The continued use of the Landauer Microstar OSLD reader
has been analysed over a three and a half year period. This
analysis shows that we have observed minor decreases in
the quality of the OSLD readouts with small increases in
the mean rread value. We can attribute these shifts to real
variability in the process chiefly the wear on the nanoDot
adapter used in the readout of OSLDs. We find that the
stability of the reader over this period has been acceptable
Fig. 4 ECF plotted against rread for batches 13–16. The mean rread varies from 0.55 to 0.76 %. This result indicates the reader stability is
maintained at previously accepted values
σaudit = 1.3% 
σaudit = 1.4% 










Reader 1 Reader 2
Fig. 5 The mean rread for each
readout session of each batch.
The uncertainty in the mean
rread value has been established
and is indicated by the marker
size
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as there has been no necessity to change the audit outcome
scores over this timeframe. The ACDS will continue to
monitor the stability of the two readers to prevent an
increase in Uread impacting the results of the level one
audit. Additionally we observed that the width of the ECF
distributions can vary by up to 3 %. This variation was not
attributed to readout uncertainty but due to an actual var-
iation in the OSLD nanodot stock used by the ACDS.
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